Director dealings: Paypoint CEO ups stake

Paypoint revealed on Friday that chief executive Nick Wiles had acquired 15,000 ordinary shares in the London-listed bill payment service provider.

Wiles, who took over as CEO back in 2019, purchased the shares at an average price of 635.50p each, for a total value of £95,325.

Back in April, analysts at Canaccord Genuity raised their target price on PayPoint from 800.0p to 825.0p, stating a return to growth was "likely" as it highlighted some "material re-rating potential".

As of 1610 BST, Paypoint shares were up 1.90% at 643.0p.

Top Director Buys

M&g (MNG)
Director name: Foley,John W.
Amount purchased: 50,000 @ 223.88p
Value: £111,940.00

Paypoint (PAY)
Director name: Wiles ,Nick
Amount purchased: 15,000 @ 635.50p
Value: £95,325.00

Glanbia (cdi) (GLB)
Director name: Lodge ,Jane Ann
Amount purchased: 5,000 @ 14.26
Value: 71,300.00

Glaxosmithkline (GSK)
Director name: Bancroft,Charles
Amount purchased: 2,939 @ $19.67
Value: $47,682.71

Glaxosmithkline (GSK)
Director name: Symonds,Jonathan
Amount purchased: 3,113 @ 1,405.00p
Value: £43,737.65

Glaxosmithkline (GSK)
Director name: Glimcher,Laurie
Amount purchased: 2,099 @ $19.63
Value: $33,967.90

Hammerson (HMSO)
Director name: Butterworth,Mike
Amount purchased: 81,463 @ 36.49p
Value: £29,725.85

Secure Trust Bank (STB)
Director name: Forsyth,Michael Bruce
Amount purchased: 1,200 @ 1,380.00p
Value: £16,560.00

Intercontinental Hotels Group (IHG)
Director name: Soares,Daniela Barone
Amount purchased: 316 @ 4,721.58p
Value: £14,920.19

Glaxosmithkline (GSK)
Director name: Goodman,Jesse
Amount purchased: 693 @ $19.63
Value: $11,214.75

Caledonia Mining Corporation (di) (CMCL)
Director name: Holtzhausen ,Johan
Amount purchased: 1,200 @ 889.00p
Value: £10,668.00

Glaxosmithkline (GSK)
Director name: Elsenhans,Lynn
Amount purchased: 567 @ $19.63
Value: $9,175.70

Glaxosmithkline (GSK)
Director name: Banga,Manvinder Singh
Amount purchased: 645 @ 1,405.00p
Value: £9,062.25

Glaxosmithkline (GSK)
Director name: Cox,Vivienne
Amount purchased: 600 @ 1,405.00p
Value: £8,430.00

Glaxosmithkline (GSK)
Director name: Rohner,Urs
Amount purchased: 600 @ 1,405.00p
Value: £8,430.00

Uls Technology (ULS)
Director name: Scott,Oliver Rupert Andrew
Amount purchased: 7,838 @ 73.77p
Value: £5,781.74

Uls Technology (ULS)
Director name: Scott,Oliver Rupert Andrew
Amount purchased: 6,000 @ 74.00p
Value: £4,440.00

Glaxosmithkline (GSK)
Director name: Beal,Anne
Amount purchased: 245 @ $19.67
Value: $3,974.91

Galantas Gold Corp. (GAL)
Director name: Stifano,Mario
Amount purchased: 3,000 @ $0.58
Value: $1,029.40

Galantas Gold Corp. (GAL)
Director name: Stifano,Mario
Amount purchased: 2,500 @ $0.58
Value: $857.84

Top Director Sells

Thg (THG)
Director name: Thorne,Zillah Byng-
Amount sold: 237,780 @ 587.00p
Value: £1,395,768.57

Vitec Group (VTC)
Director name: Green,Martin
Amount sold: 40,000 @ 1,550.00p
Value: £620,000.00

Vitec Group (VTC)
Director name: Bolton,Jon
Amount sold: 12,050 @ 1,550.00p
Value: £186,775.00

Renalytix (reg S) (RENX)
Director name: Sterling,James
Amount sold: 12,000 @ $14.00
Value: $138,533.85

Fbd Holdings (cdi) (FBH)
Director name: O'Grady,John
Amount sold: 12,297 @ 7.50
Value: 92,227.50